IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

PERROTTA, Fabio Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.803
EU - Europa 4.945
AS - Asia 1.759
SA - Sud America 480
AF - Africa 344
Continente sconosciuto - Info sul continente non disponibili 185
OC - Oceania 12
Totale 13.528
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.642
RU - Federazione Russa 2.230
IE - Irlanda 776
SG - Singapore 743
IT - Italia 480
CN - Cina 390
BR - Brasile 356
CI - Costa d'Avorio 270
FR - Francia 224
DE - Germania 213
AT - Austria 194
FI - Finlandia 183
UA - Ucraina 167
GB - Regno Unito 151
VN - Vietnam 118
HK - Hong Kong 100
SE - Svezia 91
CA - Canada 89
IN - India 81
PL - Polonia 79
BD - Bangladesh 73
AR - Argentina 38
BE - Belgio 32
JP - Giappone 31
NL - Olanda 31
ID - Indonesia 30
TR - Turchia 30
ZA - Sudafrica 28
IQ - Iraq 26
CO - Colombia 25
MX - Messico 22
ES - Italia 21
LT - Lituania 20
VE - Venezuela 19
MY - Malesia 17
EC - Ecuador 16
CL - Cile 13
PH - Filippine 12
AU - Australia 11
PK - Pakistan 11
SA - Arabia Saudita 11
JM - Giamaica 10
KR - Corea 9
EU - Europa 8
IL - Israele 8
IR - Iran 8
MA - Marocco 8
NP - Nepal 8
UZ - Uzbekistan 8
CR - Costa Rica 7
EG - Egitto 7
JO - Giordania 7
SV - El Salvador 7
AZ - Azerbaigian 6
DZ - Algeria 6
HN - Honduras 6
KE - Kenya 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
PA - Panama 5
PT - Portogallo 5
RO - Romania 5
TN - Tunisia 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
GR - Grecia 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LV - Lettonia 4
NI - Nicaragua 4
PE - Perù 4
TT - Trinidad e Tobago 4
AL - Albania 3
BG - Bulgaria 3
DK - Danimarca 3
ET - Etiopia 3
HU - Ungheria 3
LK - Sri Lanka 3
RS - Serbia 3
SC - Seychelles 3
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GT - Guatemala 2
LY - Libia 2
NO - Norvegia 2
OM - Oman 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
BB - Barbados 1
BS - Bahamas 1
BW - Botswana 1
GE - Georgia 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
MD - Moldavia 1
Totale 13.339
Salva come PNG Salva come JPEG
Città #
Dallas 938
Dublin 775
Moscow 749
San Jose 682
Chandler 439
Singapore 399
Ashburn 386
Jacksonville 382
Abidjan 270
Vienna 191
Helsinki 157
Council Bluffs 154
The Dalles 152
Beijing 134
Ann Arbor 117
Wilmington 106
Hong Kong 98
Lauterbourg 90
Milan 87
Los Angeles 84
San Mateo 78
New York 76
Rome 76
Warsaw 75
Princeton 69
Houston 67
Santa Clara 66
Frankfurt am Main 65
Woodbridge 50
Columbus 47
Boardman 44
Ho Chi Minh City 44
Dearborn 42
São Paulo 38
Charlestown 37
Orem 36
London 32
Brussels 30
Tokyo 29
Toronto 29
Phoenix 28
Brooklyn 24
Chennai 23
Miano 21
Manchester 20
Molise 20
Redwood City 20
Atlanta 19
Hanoi 19
Seattle 19
Amsterdam 18
Chicago 18
Grover Beach 18
Montreal 18
San Francisco 18
Denver 17
Naples 16
Johannesburg 15
Jinan 14
Ottawa 14
Hillsboro 12
Rio de Janeiro 12
Apopka 11
Baghdad 11
Janesville 11
Mexico City 11
Mountain View 11
Washington 11
Ankara 10
Brasília 10
Dhaka 10
Falkenstein 10
Stockholm 10
Guangzhou 9
Nanjing 9
Rochester 9
Augusta 8
Boston 8
Caracas 8
Figino 8
Istanbul 8
Newark 8
Poplar 8
Porto Alegre 8
Borås 7
Esslingen am Neckar 7
Jakarta 7
Kingston 7
Leawood 7
Mumbai 7
New Delhi 7
Plymouth Meeting 7
San Salvador 7
Seoul 7
Shanghai 7
Shenyang 7
Tashkent 7
Zhengzhou 7
Amman 6
Ardabil 6
Totale 8.140
Salva come PNG Salva come JPEG
Nome #
Spondiloartriti assiali: dalla patogenesi della neoformazione ossea alla valutazione di possibili biomarcatori di attività di malattia e remissione clinica 347
An ultrasonographic study of enthesis in early psoriatic arthritis patients naive to traditional and biologic DMARDs treatment 263
An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings 227
Assessment of response to treatment, remission, and minimal disease activity in axial psoriatic arthritis treated with tumor necrosis factor inhibitors 225
Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting 219
An overview of low disease activity and remission in psoriatic arthritis. 218
Assessment of bone morphogenic protein 2 and interleukine-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study 200
Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis 198
Assessment of subclinical atherosclerosis in ankylosing spondylitis: Correlations with disease activity indices 198
Chronic periaortitis with retroperitoneal fibrosis successfully treated with first line tocilizumab monotherapy: a case report 195
Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis 194
Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patients 191
From clinical remission to residual disease activity in spondyloarthritis and its potential treatment implications 190
Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study. 182
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: Association with disease activity and quality of life indices 182
Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab 178
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 175
Incidence of rheumatoid arthritis, psoriatic arthritis and polymyalgia rheumatica in an inland area of central Italy: results of the CAMPO-RHE study 171
Validity, responsiveness and feasibility of an Italian version of the Canadian Occupational Performance Measure for patients with ankylosing spondylitis 170
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients 162
Mesenchimal stem cells: A possible role in the pathogenesis and treatment of spondyloarthritis 160
Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study 160
Assessment of widespread and extra-articular pain in psoriatic arthritis: a case-control study 160
Assessment of Patient-Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study 158
Patient's global assessment as an outcome measure for psoriatic arthritis in clinical practice: A surrogate for measuring low disease activity? 157
Subcutaneous anti-TNF alfa induced sustained minimal disease activity and remission in psoriatic arthritis patients: a retrospective study 156
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs 153
Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study. 153
The role of IL-17 in the treatment of psoriatic arthritis 151
Assessment of Carpal Tunnel Syndrome in Patients With Wrist Involvement During the Course of Inflammatory Arthritis. A Cross-Sectional Study 149
Clinical and ultrasonography assessment of peripheral enthesitis in ankylosing spondylitis 148
Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis 147
Cardiovascular comorbidities in psoriatic arthritis: epidemiology and risk factors in two different European populations 146
Comparison of composite indices tailored for psoriatic arthritis treated with csDMARD and bDMARD: A cross-sectional analysis of a longitudinal cohort 146
Dr. Lubrano, et al reply 146
Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study 145
Clinical and imaging assessment of peripheral enthesitis in Ankylosing Spondylitis 144
Constrictive Pericarditis With Massive Calcification in Systemic Sclerosis Treated With Pericardiectomy: A Case Report 141
Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs 141
Predictors of loss of remission and disease flares in patients with axial spondyloarthritis receiving antitumor necrosis factor treatment: A retrospective study 141
Unmet Needs in Axial Spondyloarthritis 141
Multimorbidity and comorbidity in psoriatic arthritis–a perspective 141
Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study 139
Role of comorbidities in spondyloarthritis including psoriatic arthritis 139
Difficult-to-treat concept in Psoriatic Arthritis: analysis of two potential definitions in a large group of patients. A cross-sectional study 135
Clinical Characteristics of Potential "Difficult-to-treat" Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 133
Defining low disease activity states in psoriatic arthritis using novel composite disease instruments 133
Secukinumab for ankylosing spondylitis and psoriatic arthritis 133
Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis. 132
Elderly psoriatic arthritis patients on TNF-α blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate 126
The Conundrum of Psoriatic Arthritis: a Pathogenetic and Clinical Pattern at the Midpoint of Autoinflammation and Autoimmunity 124
Psoriatic arthritis: is it time to treat-to-target or target to treat? 121
Impact of physical activity on disability risk in elderly patients hospitalized for mild acute diverticulitis and diverticular bleeding undergone conservative management 121
The sex influence on response to tumor necrosis factor-α inhibitors and remission in axial spondyloarthritis 119
Occult axial involvement in patients with psoriatic arthritis mutilans: a case report 119
New approved drugs for psoriatic arthritis. 118
Effectiveness of adalimumab for the treatment of psoriatic arthritis: An Italian real-life retrospective study 118
Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study 116
TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis 115
To move or not to move: The paradoxical effect of physical exercise in axial spondyloarthritis 113
Psoriatic arthritis, psoriatic disease, or psoriatic syndrome? 111
Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study 111
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis 110
Power Doppler ultrasonographic evaluation of enthesitis in psoriatic arthritis. A multi-center study 110
New Insights in Physical Therapy and Rehabilitation in Axial Spondyloarthritis: A Review 110
Psoriatic Arthritis in Males and Females: Differences and Similarities 109
Residual disease activity and associated factors in Psoriatic Arthritis 108
Ultrasound description of cortical-entheseal bone remodeling in peripheral entheses of patients with psoriasis and nonspecific musculoskeletal symptoms 107
Ultrasonographic and Clinical Assessment of Peripheral Enthesitis in Patients with Psoriatic Arthritis, Psoriasis, and Fibromyalgia Syndrome: The ULISSE Study 107
Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study 106
Clinical Characteristics of "Severe" Peripheral Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 104
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis 100
Rheumatology Care in the Face of COVID-19 97
Valutazione ecografica del tendine di Achille e dell'entesi rotulea nei giocatori di calcio e basket: potrebbe essere utile per prevedere lo sviluppo di lesioni muscolari e tendinee? 96
MRI Assessment of Extra-axial Findings at Pelvic Sites in a Group of Axial-SpA Patients 96
Long-Term Survival of Methotrexate as First-Line Therapy in Rheumatoid Arthritis, Psoriatic Arthritis and Undifferentiated Arthritis 94
Visceral muscle dysmotility syndrome in systemic lupus erythematosus: which is the role of 18 fluorodeoxyglucose-positron emission tomography-computed tomography? A clinical case and literature review 91
Psychological Health in the Management of Patients with Psoriatic Arthritis: An Intricate Relationship 88
Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts 87
Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective 87
SARS-CoV-2 IgM False-Positivity in a Psoriatic Arthritis Patient Seropositive for Rheumatoid Factor and ACPA: An Interference of Immune Response? 87
New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review 86
The "Climb" Towards Minimal Disease Activity in Psoriatic Arthritis 86
The holistic management of peripheral spondyloarthritis: focus on articular involvement in patients with inflammatory bowel disease 86
Therapeutic Targets for Ankylosing Spondylitis - Recent Insights and Future Prospects 84
Valutazione dei fattori predittivi per il raggiungimento della remissione parziale (RP) secondo i criteri ASAS nei pazienti con Spondilite Anchilosante (SA) trattati con farmaci antagonisti del TNF 82
Ultrasonographic Evaluation of Entheseal Fibrocartilage in Patients with Psoriatic Arthritis, Athletes and Healthy Controls: A Comparison Study 81
Triple jump for the optimal management of psoriatic arthritis: Diet, sleep and exercise - A review 79
Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk 78
Elevated levels of IL-19 in the joints of patients with psoriatic arthritis 74
Patient reported outcomes in early vs late diagnosis of psoriatic arthritis|Resultados informados por los pacientes en el diagnóstico precoz respecto a los pacientes con diagnóstico tardío en la artritis psoriásica 73
Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician 73
Evaluation of the “Multivariable Psoriatic Arthritis Risk Estimation Tool” in a Cohort of Patients with Psoriasis: Preliminary Results of a Prospective Observational Study 72
Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE Study 72
Male Fertility in Spondyloarthritis: from Clinical Issues to Cytokines Milieu. A Narrative Review 72
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 71
Sex-related differences in psoriatic arthritis 69
Two sides of management recommendations for psoriatic arthritis 69
Livelli aumentati di IL19 nel liquido sinoviale di pazienti con artrite psoriasica 66
Characterization of Super-Responder Profile in Patients with Psoriatic Arthritis Treated with b/tsDMARDs: A Retrospective Study of a Longitudinal Cohort 65
Totale 13.177
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.167
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022252 0 0 0 17 17 7 10 38 49 71 14 29
2022/20231.805 218 74 34 151 68 126 15 86 895 67 39 32
2023/2024473 132 68 34 19 23 51 2 33 17 23 19 52
2024/20251.668 319 69 193 21 285 36 21 96 163 55 174 236
2025/20266.221 205 482 705 377 1.418 1.207 619 243 253 535 101 76
2026/20271.290 133 215 503 439 0 0 0 0 0 0 0 0
Totale 13.528